Coya Therapeutics, Inc. - Common Stock
Coya Therapeutics, Inc. - Common Stock
Aktie · US22407B1089 · COYA (XNAS)
Übersicht Finanzkennzahlen
5,59 USD
-1,93 % -0,11 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 22:37

Aktuelle Kurse von Coya Therapeutics, Inc. - Common Stock

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
COYA
USD
06.06.2025 22:37
5,59 USD
5,70 USD
-1,93 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 6,07 % -4,44 % -12,38 % -7,83 % -19,91 % 22,32 %

Firmenprofil zu Coya Therapeutics, Inc. - Common Stock Aktie

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.

Unternehmensdaten

Name Coya Therapeutics, Inc. - Common Stock
Firma Coya Therapeutics, Inc.
Symbol COYA
Website https://www.coyatherapeutics.com
Heimatbörse XNAS NASDAQ
ISIN US22407B1089
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Arun Swaminathan Ph.D.
Marktkapitalisierung 89 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 5850 San Felipe Street, 77057 Houston
IPO Datum 2022-12-29

Ticker Symbole

Name Symbol
NASDAQ COYA

Weitere Aktien

Investoren die Coya Therapeutics, Inc. - Common Stock die halten, haben auch folgende Aktien im Depot:
CERILLION PLC - ORD 0.5P
CERILLION PLC - ORD 0.5P Aktie
H WORLD GROUP 21/26 CV
H WORLD GROUP 21/26 CV Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025